STOCK TITAN

Capitalink Ltd. stakes 4.99% in X Labs Inc. (QXL) with warrants noted

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Capitalink Ltd. amended its Schedule 13G to report beneficial ownership in X Labs Inc. The filing states Capitalink beneficially owns 667,034 shares, representing 4.99% of X Labs' 13,336,392 shares outstanding used for the calculation. The filing counts 38,000 additional shares issuable upon exercise of warrants within 60 days and notes a 44,283-share warrant subject to a blocker provision.

Positive

  • None.

Negative

  • None.

Insights

Routine disclosure of sub-5% ownership with derivative interests.

Capitalink Ltd. reports beneficial ownership of 667,034 shares, equal to 4.99% based on 13,336,392 shares outstanding stated in the filing. The report includes 38,000 warrants exercisable within 60 days.

Filing preserves a blocker provision limiting exercise of an additional 44,283-share warrant to avoid exceeding 4.99%. Subsequent filings would show any change if warrants are exercised or additional acquisitions occur.

Disclosure signals a passive stake under the 5% threshold.

The filing characterizes the position as passive: ownership is reported at 4.99% and the Schedule 13G/A framework applies. The report lists dispositive and voting power tied to 667,034 shares.

Because an exercise cap is documented, actual post-exercise ownership depends on future exercises and any blocking mechanics; cash‑flow treatment is not detailed in the excerpt.

Reported shares beneficially owned 667,034 shares Beneficial ownership reported by Capitalink Ltd.
Percent of class 4.99% Calculated using 13,336,392 shares outstanding
Shares outstanding used for calculation 13,336,392 shares Issuer-provided outstanding share count used in the filing
Warrants exercisable within 60 days (counted) 38,000 shares Included in beneficial ownership calculation
Warrant with blocker provision 44,283 shares Exercise limited to avoid exceeding 4.99% beneficial ownership
Schedule 13G/A regulatory
"Amendment No. 1 ) X LABS INC. Common Stock"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: See items 5-11 of the cover pages"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
blocker provision legal
"blocker provision under which the Reporting Person does not have the right to exercise the warrant"
warrant financial
"issuable upon the exercise of warrants held by the Reporting Person"
A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.





926711300

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: * Percentage calculated based on 13,336,392 shares of common stock, $0.0001 par value per share (the "Shares"), of Quantum X Labs Inc. (the "Issuer") issued and outstanding as of the date hereof, which amount was provided to the Reporting Person by the Issuer.


SCHEDULE 13G



Capitalink Ltd.
Signature:/s/ Lavi Krasney
Name/Title:Lavi Krasney/Chief Executive Officer
Date:05/15/2026

FAQ

What is the effect of the blocker provision mentioned in the filing?

The blocker provision prevents exercising a warrant to the extent it would cause beneficial ownership to exceed 4.99%. The filing cites this limit tied to the Reporting Person and related parties.

What outstanding share count does the filing use to compute the percentage?

The filing uses 13,336,392 shares of common stock as the issuer-provided figure for shares issued and outstanding as of the date referenced in the filing.